Semaglutide Linked to Fewer Cognitive Symptoms in Psychiatric Disorders
Semaglutide initiation was associated with fewer clinician-recorded cognitive signs and symptoms among adults with psychiatric disorders, according to a poster presented at Psych Congress. General Psychiatry Conference Coverage